This site is intended for healthcare professionals
News

Update on KESTREL phase III trial of Imfinzi with or without tremelimumab in the 1st-line treatment of recurrent or metastatic head and neck cancer.- AstraZeneca

Read time: 1 mins
Last updated:7th Feb 2021
Published:7th Feb 2021
Condition: Head & Neck Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest